AFJK
Aimei Health Technology Co., Ltd Ordinary Share
NASDAQ: AFJK · FINANCIAL SERVICES · SHELL COMPANIES
$43.00
-0.02% today
Updated 2026-06-05
Market cap
$126.65M
P/E ratio
235.29
P/S ratio
—
EPS (TTM)
$0.17
Dividend yield
—
52W range
$7 – $130
Volume
0.0M
Aimei Health Technology Co., Ltd Ordinary Share (AFJK) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-52.4%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.9%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.1%
2025-12-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $0.02 | — | $82.58 | $75.86 | -8.1% |
| 2025-11-18 | $0.06 | — | $11.01 | $10.39 | -5.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $0.02 | — | — | — |
| 2025-09-30 | — | $0.06 | — | — | — |
| 2025-06-30 | — | $0.07 | — | — | — |
| 2025-03-31 | — | $0.03 | — | — | — |
| 2024-12-31 | — | $0.05 | — | $1.33M | — |
| 2024-09-30 | — | $0.08 | — | — | — |
| 2024-06-30 | — | $0.07 | — | — | — |
| 2024-03-31 | — | $0.08 | — | — | — |
Frequently asked questions
Has Aimei Health Technology Co., Ltd Ordinary Share beaten earnings estimates?
Aimei Health Technology Co., Ltd Ordinary Share has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.
How does AFJK stock react to earnings?
AFJK has moved an average of -6.9% the day after earnings over its last 2 reports, finishing higher after 0 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.